Gerresheimer AG (ETR:GXI)
27.52
-0.20 (-0.72%)
Oct 2, 2026, 5:35 PM CET
Gerresheimer AG Market Cap
Gerresheimer AG has a market cap or net worth of €957.45 million as of October 2, 2026. Its market cap has decreased by -24.96% in one year.
Market Cap
957.45M
Enterprise Value
3.02B
Revenue
2.32B
Ranking
n/a
PE Ratio
n/a
Stock Price
€27.52
ChartMarket Cap Chart
Since June 11, 2007, Gerresheimer AG's market cap has decreased from 1.20B to 957.45M, a decrease of -20.49%. That is a compound annual growth rate of -1.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 957.45M | 0.51% |
| Dec 30, 2025 | 952.61M | -61.15% |
| Dec 30, 2024 | 2.45B | -24.75% |
| Dec 29, 2023 | 3.26B | 65.26% |
| Dec 30, 2022 | 1.97B | -25.86% |
| Dec 30, 2021 | 2.66B | -3.48% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 58.46B |
| Bayer Aktiengesellschaft | 44.60B |
| Siemens Healthineers AG | 41.86B |
| Fresenius SE & Co. KGaA | 24.67B |
| Drägerwerk AG & Co. KGaA | 1.93B |
| Dermapharm Holding SE | 1.90B |
| Redcare Pharmacy NV | 1.42B |
| RHÖN-KLINIKUM Aktiengesellschaft | 970.61M |